Ignacio Vázquez-García
Ignacio Vázquez-García
Verified email at mskcc.org - Homepage
Title
Cited by
Cited by
Year
The repertoire of mutational signatures in human cancer
LB Alexandrov, J Kim, NJ Haradhvala, MN Huang, AWT Ng, Y Wu, A Boot, ...
Nature 578 (7793), 94-101, 2020
4892020
Pan-cancer analysis of whole genomes
I The, TPCA of Whole, Genomes Consortium
Nature 578 (7793), 82, 2020
3932020
The evolutionary history of 2,658 cancers
M Gerstung, C Jolly, I Leshchiner, SC Dentro, S Gonzalez, D Rosebrock, ...
Nature 578 (7793), 122-128, 2020
2722020
High-definition reconstruction of clonal composition in cancer
A Fischer, I Vázquez-García, CJR Illingworth, V Mustonen
Cell Reports 7 (5), 1740–1752, 2014
1632014
Clonal Decomposition and DNA Replication States Defined by Scaled Single-Cell Genome Sequencing
E Laks, A McPherson, H Zahn, D Lai, A Steif, J Brimhall, J Biele, B Wang, ...
Cell 179 (5), 1207-1221. e22, 2019
422019
The value of monitoring to control evolving populations
A Fischer, I Vázquez-García, V Mustonen
Proceedings of the National Academy of Sciences 112 (4), 1007–1012, 2015
412015
Portraits of genetic intra-tumour heterogeneity and subclonal selection across cancer types
SC Dentro, I Leshchiner, K Haase, M Tarabichi, J Wintersinger, ...
BioRxiv, 312041, 2018
312018
A community effort to create standards for evaluating tumor subclonal reconstruction
A Salcedo, M Tarabichi, SMG Espiritu, AG Deshwar, M David, NM Wilson, ...
Nature Biotechnology 38 (1), 97-107, 2020
272020
Clonal Heterogeneity Influences the Fate of New Adaptive Mutations
I Vázquez-García, F Salinas, J Li, A Fischer, B Barré, J Hallin, A Bergström, ...
Cell Reports 21 (3), 732-744, 2017
232017
Shared molecular targets confer resistance over short and long evolutionary timescales
J Li, I Vázquez-García, K Persson, A González, JX Yue, B Barré, MN Hall, ...
Molecular biology and evolution 36 (4), 691-708, 2019
102019
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes
SC Dentro, I Leshchiner, K Haase, M Tarabichi, J Wintersinger, ...
Cell, 2021
62021
Contrasting the impact of cytotoxic and cytostatic drug therapies on tumour progression
JV Anttila, M Shubin, J Cairns, F Borse, Q Guo, T Mononen, ...
PLoS computational biology 15 (11), e1007493, 2019
52019
Pervasive intra-tumour heterogeneity and subclonal selection across cancer types
S Dentro, I Leshchiner, K Haase, J Wintersinger, A Deshwar, M Tarabichi, ...
Cancer Research 78 (13 Supplement), 3000-3000, 2018
52018
BRCA Mutations, Homologous DNA Repair Deficiency, Tumor Mutational Burden, and Response to Immune Checkpoint Inhibition in Recurrent Ovarian Cancer
YL Liu, P Selenica, Q Zhou, A Iasonos, M Callahan, NZ Feit, J Boland, ...
JCO Precision Oncology 4, 665-679, 2020
12020
Sex differences in oncogenic mutational processes
SD Prokopec, RX Sun, F Yousif, N Schmitz, F Al-Shahrour, G Atwal, ...
Nature Publishing Group UK, 2020
2020
The evolutionary history of 2,658 cancers
C Jolly, I Leshchiner, SC Dentro, S Gonzalez, D Rosebrock, TJ Mitchell, ...
Nature Publishing Group UK, 2020
2020
Principles of systems biology, no. 22
I Vázquez-García, V Mustonen, G Liti
Cell Systems 5 (14), 305-309, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–17